A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2006
11/01/2006	CN1853728A Method prescription and use for improving medicine or nutrient oral absorption
11/01/2006	CN1853727A Polysaccharide-containing compositions and use thereof
11/01/2006	CN1853726A Polymer system for improving insoluble medicine water solubility and preparation thereof
11/01/2006	CN1853725A Methods for pulmonary delivery of interleukin-2
11/01/2006	CN1853644A Treatment and prophylaxis of diseases and infections pigs and poultry
11/01/2006	CN1853640A Doxycycline hyclate liposome and production thereof
11/01/2006	CN1853635A Use of triazinetrione sulfones for combating coccidiosis
11/01/2006	CN1853627A Cyclodextrin of bibenziisosehenazole ethane or cyclodextrin derivative inclusion compound, and preparation and use thereof
11/01/2006	CN1853617A Medicine based on anti-hyperglycaemic microcapsules with prolonged release
11/01/2006	CN1282486C Vaccine compsn. comprising at least two valences, one enhanced with adjuvant and not other
11/01/2006	CN1282456C Paroxetine control-released composite
10/2006
10/31/2006	US7129332 Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
10/31/2006	US7129327 Polypeptide and protein derivatives and process for their preparation
10/31/2006	US7129292 Method for the emulsion polymerization of olefins
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129254 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates
10/31/2006	US7129230 Method and product for treating cancer in pets
10/31/2006	US7129222 Immunomodulatory formulations and methods for use thereof
10/31/2006	US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group
10/31/2006	US7129218 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
10/31/2006	US7129203 Deleting at least one amino acid residue on the protein, and contacting the protein with polyethylene glycol under conditions sufficient to conjugate the polyethylene glycol to the protein
10/31/2006	US7128928 Ophthalmic formulation with novel gum composition
10/31/2006	US7128927 Emulsions for in-situ delivery systems
10/31/2006	US7128923 Mixture with non-formaldehyde preservative; microbiocides; chemical resistance; drugs, medical equipment, cosmetics; antiaging, wrinkle resistance; skin disorders
10/31/2006	US7128922 Compositions of leukaemia inhibitory factor
10/31/2006	US7128913 Erythropoietin conjugates
10/31/2006	US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide
10/31/2006	US7128909 For parenteral or mucosal administration of antigens and/or vaccines to humans and animals
10/31/2006	US7128897 Having surface tension, effective for therapy of respiratory systme disorders
10/31/2006	US7128893 Used to target radionuclides to cells, such as a variety of tumor cell types, for use in diagnostic imaging; peptide derivatives of vitamins such as folate, riboflavin, thiamine, vitamin B12, and biotin chelated to a radionuclide
10/31/2006	US7128067 Method and apparatus for generating an aerosol
10/31/2006	CA2333405C Spill resistant pharmaceutical compositions
10/31/2006	CA2329217C Stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/31/2006	CA2302850C Stretch mask with an adhesive matrix that can be extended at least when wet
10/31/2006	CA2281474C Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof
10/31/2006	CA2267160C Antimycotic gel for the treatment and prevention of skin mycoses
10/31/2006	CA2236925C Microencapsulated dna for vaccination and gene therapy
10/31/2006	CA2209303C Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
10/31/2006	CA2190370C Composition and method for enhancing transdermal electrotransport agent delivery
10/31/2006	CA2188599C Taxane class derivative based pharmaceutical compositions
10/31/2006	CA2157376C Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
10/31/2006	CA2136953C A method for using lipoprotein associated coagulation inhibitor to treat sepsis
10/31/2006	CA2136751C Salts of peptides with carboxy-terminated polyesters
10/27/2006	CA2505470A1 Drug delivery device
10/26/2006	WO2006112838A1 Stabilized anti-hepatitis b (hbv) antibody formulations
10/26/2006	WO2006112777A2 Uses of rhcc in drug delivery, real filtering, chemical catalysis and production of nanoparticles
10/26/2006	WO2006112541A1 Method for the design of self-emulsifying drug formulations
10/26/2006	WO2006112533A1 Water-containing gel form and production method thereof
10/26/2006	WO2006112476A2 Biodegradable nanoparticle having antigen immobilized thereon and vaccine comprising the same
10/26/2006	WO2006112362A1 Process for production of polymer-type therapeutic agent for treatment of cancer
10/26/2006	WO2006112361A1 Polymeric pharmaceutical agent for treatment of cancer and process for production of the same
10/26/2006	WO2006112276A1 Propofol-containing fat emulsion
10/26/2006	WO2006112254A1 External preparation, method of applying external preparation, iontophoresis device and transdermal patch
10/26/2006	WO2006112239A1 hTERT GENE EXPRESSION REGULATORY GENE
10/26/2006	WO2006112222A1 Branched starch, process for production thereof, and use thereof
10/26/2006	WO2006111844A1 Use of azithromycin for the production of a medicament for treatment of ocular infections
10/26/2006	WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006	WO2006092727A3 Process for the production of calcium compositions in a continuous fluid bed
10/26/2006	WO2006084902A3 Method of purifying a surfactant by ultrafiltration
10/26/2006	WO2006032018A3 Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor
10/26/2006	WO2005082338A3 Prodrugs for the intravenous administration of proton pump inhibitors
10/26/2006	WO2005067980A3 Design of therapeutics and therapeutics
10/26/2006	WO2005048976A3 Foams comprising a sclerosing and a viscosity enhancing agent, methods for production thereof
10/26/2006	WO2004078147A3 Oxytocin controlled release formulations and methods of using same
10/26/2006	US20060241170 Methods and formulations of taxanes
10/26/2006	US20060241047 FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and
10/26/2006	US20060241021 Methods of treating cognitive dysfunction by modulating brain energy metabolism
10/26/2006	US20060241019 Long lasting insulin derivatives and methods thereof
10/26/2006	US20060240539 A Streptococcus thermophilus deposited on 26th Feb. 2003 at the Collection Nationale de Cultures de Microorganismes under number I-2980; extends shelf-life of dairy product; fermentation
10/26/2006	US20060240525 Factor VII or VIIa - Like Molecules
10/26/2006	US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/26/2006	US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
10/26/2006	US20060240168 Chitosan foodstuff
10/26/2006	US20060240123 Pharmaceutical composition
10/26/2006	US20060240114 Drug for treating hemophilia and method of treating hemophilia using the same
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	US20060240088 Caged ligands and uses thereof
10/26/2006	US20060240086 Adhesive patch
10/26/2006	US20060240080 Alginate sponge and preparation method thereof
10/26/2006	US20060240076 Preparation and use of hydrogels
10/26/2006	US20060240075 Carnitine retention
10/26/2006	US20060240074 Preferred salts are triple metal salts of calcium, magnesium or zinc and potassium; tasteless, odorless and highly water soluble; used in beverages, neutraceuticals and for treating obesity
10/26/2006	US20060240052 Ketoprofen compositions and methods of making them
10/26/2006	US20060240050 Stable clozapine suspension formulation
10/26/2006	US20060240048 Pyridine derivatives as cb2 receptor modulators
10/26/2006	US20060240009 Liposome composition for improved intracellular delivery of a therapeutic agent
10/26/2006	US20060239997 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
10/26/2006	US20060239961 Hydrolytically degradable alkylene oxide based polymers
10/26/2006	US20060239936 Delivery of anti-migraine compounds through an inhalation route
10/26/2006	US20060239924 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
10/26/2006	CA2649263A1 Biodegradable polyphosphazenes containing pyrrolidone side groups
10/26/2006	CA2606224A1 External preparation, method of applying external preparation, iontophoresis device, and percutaneous patch
10/26/2006	CA2604840A1 Stabilized anti-hepatitis b (hbv) antibody formulations
10/26/2006	CA2603833A1 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1714656A1 Ed-71 preparation
10/25/2006	EP1714653A1 Aqueous solution preparation containing camptothecins
10/25/2006	EP1714643A1 Sustained release preparation
10/25/2006	EP1714640A1 Stabilised external skin treatment composition comprising retinol.
10/25/2006	EP1713514A2 Drugs and gene carrier particles that rapidly move through mucous barriers

1 ... 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 ... 1712